June 01, 2021
Most Popular Cardiology Technology Content in May 2021
June 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
Illustration of how spectral CT can help confirm findings on a conventional CT scan without requiring follow-up imaging, such as a nuclear scan. The conventional CT on the left, and the dual-energy CT on the right confirms an infarct.
May 27, 2021
Philips Introduces the new Spectral CT 7500 as Workhorse Scanner With Spectral Data on Every Scan
May 27, 2021 — Philips Healthcare released a workhorse computed tomography (CT) system, the Spectral CT 7500, which has…
Read More
The Acurate neo2 TAVR valve design enhancements include a 60% larger outer sealing skirt to conform to challenging anatomies. This has minimized paravalvular leaks and imporved clinical outcomes compared to the previous-generation Acurate neo Aortic Valve System. #EuroPCR #EuroPCR21 #EuroPCR2021
May 26, 2021
Acurate neo2 TAVR Valve Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates 
May 26, 2021 — Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress for the updated…
Read More
Left, the AcQCross Transseptal Crossing Device offers versatility to be utilized with top sheaths currently used in left atrium EP and structural heart procedures. Right, the AcQMap next-generation mapping catheter integrates high-resolution ultrasound-based imaging and non-contact mapping catheter with improved torque response, handling and maneuverability.
May 25, 2021
Acutus Gains European CE Mark for Suite of Next Generation EP Products
May 25, 2021 — Acutus Medical Inc. announced European CE mark approval for a broad suite of electrophysiology (EP)…
Read More
iRhythm Technologies Inc. announced two new U.S. Food and Drug Administration (FDA) 510(k) clearances — one for a new and improved design of its flagship Zio wearable cardiac monitor, and a second for updated artificial intelligence (AI) capabilities. 
May 25, 2021
FDA Clears Smaller iRhythm Monitor with AI Arrhythmia Detection
May 25, 2021 — iRhythm Technologies Inc. announced two new U.S. Food and Drug Administration (FDA) 510(k) clearances —…
Read More
AGENT IDE will evaluate the AGENT DCB as potential therapy for patients with in-stent restenosis, may offer alternative to repeated stenting or radiation therapy
May 20, 2021
Boston Scientific Initiates First Coronary Drug-Coated Balloon Study in the U.S.
May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated…
Read More
RAFT-AF study showed type of heart failure may influence treatment strategies for heart rate management vs. arrhythmia control in in patients with heart  heart and atrial fibrillation. #ACC21 #ACC2021
May 19, 2021
Type of Heart Failure May Influence Optimal Approach for AFib Rhythm Control Versus Rate Control Strategy
May 19, 2021 — Among patients with both heart failure and atrial fibrillation (AFib), treatment strategies focused on…
Read More
ECMO unit in use to support a severely ill patient at the University of Michigan. ECMO was shown to imporve survival and neuro outcomes in sudden cardiac arrest patients who do not respond to standard therapy.
May 19, 2021
ECMO Increased Survival in Refractory Out-of-Hospital Cardiac Arrest
May 19, 2021 — A subgroup of patients who experienced an out-of-hospital cardiac arrest (OHCA) that did not respond to…
Read More
Cardiovascular information systems (CVIS) allow storage of in-office echocardiograms, aids report generation and reading echos for several hospitals. Hitachi’s VidiStar CVIS.
May 19, 2021
Use of CVIS for Remote Access of Data and Images
The ability of a cardiologist to work remotely can save lives. By leveraging the advantages of a cloud-based…
Read More
The WASE-COVID Study used the artificial intelligence automated echocardiogram reading software EchoGo-Core from Ultromics to evaluate ejection fraction and left ventricle longitudinal strain in COVID-19 patients to identify risk markers for mortality. The study also compared human vs. AI variability in assessing the exams. #ACC21 #ACC2021
May 18, 2021
AI Derived Cardiac Echo Measurements Able to Predict COVID-19 Mortality
May 18, 2021 — Artificial intelligence (AI) derived heart measurements were able to predict COVID-19 (SARS-CoV-2)…
Read More
AMERICAN COLLEGE OF CARDIOLOGY (ACC) Late-breaking clinical trial study presentations at ACC.21. @ACC21 @ACC2021
Dave Fornell, Editor
May 18, 2021
ACC 2021 Late Breaking Cardiology Study Results
The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced…
Read More
The results of the GALACTIC-HF trial shows omecamtiv mecarbil offers benefits to severe heart failure patients. #ACC21 #ACC2021 #GALACTICHF
May 18, 2021
GALACTIC-HF Shows Omecamtiv Mecarbil Brings Greater Benefits for Severe Heart Failure
May 18, 2021 — The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a…
Read More
Dapagliflozin did not significantly reduce organ failure or death in high-risk hospitalized COVID-19 patients in the DARE-19 trial results, presented at ACC.21. #ACC #ACC21 #ACC2021
May 18, 2021
Dapagliflozin Did Not Significantly Reduce Organ Failure or Death in High-Risk Hospitalized COVID-19 Patients
May 18, 2021 — Dapagliflozin (Farxiga), a sodium-glucose co-transporter 2 (SGLT2) inhibitor, did not significantly…
Read More
This trial used a therapeutic hypothermia system that used balloon catheters filled with cooled saline, such as the Zoll Thermogard XP temperature management system. #ACC21 #ACC2021 #therapeutichypothermia
May 17, 2021
Lower Temperature Therapeutic Hypothermia Did Not Improve Outcomes After Cardiac Arrest
May 17, 2021 — In patients receiving therapeutic hypothermia after suffering out-of-hospital cardiac arrest, those who…
Read More
The anticoagulant rivaroxaban (Xarelto), in addition to low-dose aspirin, significantly reduced the occurrence of total severe events of the heart, limb or brain and issues related to other vascular complications in patients with symptomatic peripheral artery disease (PAD) who underwent lower extremity revascularization. The findings from the VOYAGER PAD trial were presented at the American College of Cardiology (ACC) 2021 Scientific Session.
May 17, 2021
Rivaroxaban Reduces First and Total Ischemic Events in Patients with Peripheral Artery Disease
May 17, 2021 — The anticoagulant rivaroxaban (Xarelto), in addition to low-dose aspirin, significantly reduced the…
Read More
The FLOWER-MI trial presented at ACC 2021 found no benefit to FFR-guided PCI in STEMI with multi-vessel disease. #ACC21 #ACC2021 #FFR
May 17, 2021
No Benefit to FFR-guided PCI in STEMI Patients With Multi-Vessel Disease
May 17, 2021 — In patients who received a coronary stent for an ST-elevation myocardial infarction (STEMI) heart attack…
Read More
DAIC magazine won Overall Excellence Finalist/Multi-platform Package of the Year for its coverage of the COVID-19 Pandemic’s Toll on Cardiology, National. The entry won an honor mention for its coverage of the COVID pandemic. Dave Fornell is the editor of DAIC.
By Melinda Taschetta-Millane
May 17, 2021
DAIC Brings Home National, Regional Honors
Diagnostic and Interventional Cardiology (DAIC) and its sister publication Imaging Technology News (ITN) recently took…
Read More
The Record Paradise RDN catheter uses a balloon catheter filled with water to cool the vessel wall as ultrasound-based ablation energy is delivered. It delivers a ring of ablative energy to a depth of 1-6 mm. Kirtane said it requires 2-3 sonications lasting 7 seconds each in each of the main renal arteries. #ACC21 #ACC2021 #RDN
By Dave Fornell, Editor
May 16, 2021
Renal Denervation Lowers Blood Pressure in Medication-Resistant Hypertension 
May 16, 2021 — Two months after undergoing renal denervation (RDN) with the ReCor Paradise renal denervation system,…
Read More
Etripamil nasal spray was shown in a post-hoc analysis to resolve paroxysmal supraventricular tachycardia faster and more completely than placebo in most patients and reduced the number of emergency room visits for additional interventions. 
By Dave Fornell, Editor
May 16, 2021
Etripamil Nasal Spray Reduced ER Vistsis and More PSVT Resolution in New NODE-301 Analysis
May 16, 2020 — New data from in the NODE-301 Trial for the patient-administered nasal spray etripamil to resolve …
Read More
The Boston Scientific Watchman device have performed better than expected in real-world patients outside of trials since it was introduced in 2015, according to data from the NCDR LAAO Registry. #ACC21 #ACC2021 #LAA #Watchman
May 16, 2021
NCDR LAAO Registry Shows Left Atrial Appendage Occlusion Associated With Low Rate of Stroke
May 15, 2021 - Transcatheter left atrial appendage occlusion (LAAO) with a Boston Scientific Watchman device was…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now